UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Natural history of cutaneous human papillomavirus (HPV) infection in men: the HIM study

PloS one, 2014-09, Vol.9 (9), p.e104843-e104843

2014

Volltextzugriff (PDF)

Natural History of Polyomaviruses in Men: The HPV Infection in Men (HIM) Study

The Journal of infectious diseases, 2015-05, Vol.211 (9), p.1437-1446

2015

Volltextzugriff (PDF)

Prevalence and Concordance of Cutaneous Beta Human Papillomavirus Infection at Mucosal and Cutaneous Sites

The Journal of infectious diseases, 2017-07, Vol.216 (1), p.92-96

2017

Volltextzugriff (PDF)

Cutaneous Human Papillomavirus Infection and Development of Subsequent Squamous Cell Carcinoma of the Skin

Journal of Skin Cancer, 2016-01, Vol.2016 (2016), p.1-9

2016

Volltextzugriff (PDF)

Cutaneous Viral Infections Across 2 Anatomic Sites Among a Cohort of Patients Undergoing Skin Cancer Screening

The Journal of infectious diseases, 2019-02, Vol.219 (5), p.711-722

2019

Volltextzugriff (PDF)

Predictors of Immunosuppressive Regulatory T Lymphocytes in Healthy Women

Journal of Cancer Epidemiology, 2012-01, Vol.2012 (2012), p.1-8

2012

Volltextzugriff (PDF)

Prevalence of cutaneous viral infections in incident cutaneous squamous cell carcinoma detected among chronic lymphocytic leukemia and hematopoietic stem cell transplant patients

Leukemia & lymphoma, 2018-04, Vol.59 (4), p.911-917

2018

Volltextzugriff (PDF)

Abstract 3439: Interaction between cutaneous human papillomavirus infection and telomere length in association with cutaneous squamous cell carcinoma

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3439-3439

2016

Volltextzugriff (PDF)

Prospective study of seroreactivity to JC virus T-antigen and risk of colorectal cancers and adenomas

Cancer epidemiology, biomarkers & prevention, 2014-11, Vol.23 (11), p.2591-2596

2014

Volltextzugriff (PDF)

Socioeconomic factors and the risk for sarcoma

European journal of cancer prevention, 2014-11, Vol.23 (6), p.560-565

2014

Volltextzugriff (PDF)

Aspirin and Acetaminophen Use and the Risk of Cervical Cancer

Journal of lower genital tract disease, 2015-07, Vol.19 (3), p.189-193

2015

Volltextzugriff (PDF)

Merkel cell polyomavirus (MCV) T-antigen seroreactivity, MCV DNA in eyebrow hairs, and squamous cell carcinoma

Infectious agents and cancer, 2015-10, Vol.10 (1), p.35-35, Article 35

2015

Volltextzugriff (PDF)

Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide

Cancer medicine (Malden, MA), 2016-07, Vol.5 (7), p.1694-1701

2016

Volltextzugriff (PDF)

Genetic polymorphisms of ATP-binding cassette (ABC) proteins, overall survival and drug toxicity in patients with Acute Myeloid Leukemia

International journal of molecular epidemiology and genetics, 2010-01, Vol.1 (3), p.201-207

2010

Volltextzugriff (PDF)

Abstract 4960: Recent ultraviolet radiation exposure and circulating immunosuppressive T-regulatory cells

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4960-4960

2017

Volltextzugriff (PDF)

Skin homing and highly suppressive (CD45RA−CD27−) Tregs associated with ultraviolet radiation exposure

The Journal of immunology (1950), 2017-05, Vol.198 (1_Supplement), p.204-204.18

2017

Volltextzugriff (PDF)

Subsequent Primary Malignancies Among Myelodysplastic Syndrome Patients Treated with or without Lenalidomide

Blood, 2014-12, Vol.124 (21), p.413-413

2014

Volltextzugriff (PDF)

Subsequent Primary Malignancies Among Multiple Myeloma Patients Treated with or without Lenalidomide

Blood, 2014-12, Vol.124 (21), p.2129-2129

2014

Volltextzugriff (PDF)

Lenalidomide and Risk of Acute Myeloid Leukemia (AML) Transformation Among Myelodysplastic Syndrome (MDS) Patients

Blood, 2014-12, Vol.124 (21), p.1912-1912

2014

Volltextzugriff (PDF)

Abstract B58: Sunlight exposure and overall survival in melanoma, colon cancer, and non-Hodgkin's lymphoma

Cancer prevention research (Philadelphia, Pa.), 2013-11, Vol.6 (11_Supplement), p.B58-B58

2013

Volltextzugriff (PDF)

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

Oncotarget, 2016-10, Vol.7 (43), p.69097-69110

2016

Volltextzugriff (PDF)

Natural History of Cutaneous Human Papillomavirus (HPV) Infection in Men: The HIM Study: e104843

PloS one, 2014-09, Vol.9 (9)

2014

Volltextzugriff (PDF)

Isolation and characterization of a novel putative human polyomavirus

Virology (New York, N.Y.), 2017-06, Vol.506, p.45-54

2017

Volltextzugriff (PDF)

SunRISe-1: Phase 2b study of TAR-200 plus cetrelimab, TAR-200 alone, or cetrelimab alone in participants with high-risk nonmuscle-invasive bladder cancer unresponsive to Bacillus Calmette-Guérin who are ineligible for or decline radical cystectomy

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.TPS593-TPS593

2022

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(36)
Dissertationen
(1)

Sprache

Englisch
(37)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Natural history of cutaneous human papillomavirus (HPV) infection in men: the HIM study

Natural History of Polyomaviruses in Men: The HPV Infection in Men (HIM) Study

Prevalence and Concordance of Cutaneous Beta Human Papillomavirus Infection at Mucosal and Cutaneous Sites

Cutaneous Human Papillomavirus Infection and Development of Subsequent Squamous Cell Carcinoma of the Skin

Cutaneous Viral Infections Across 2 Anatomic Sites Among a Cohort of Patients Undergoing Skin Cancer Screening

Predictors of Immunosuppressive Regulatory T Lymphocytes in Healthy Women

Prevalence of cutaneous viral infections in incident cutaneous squamous cell carcinoma detected among chronic lymphocytic leukemia and hematopoietic stem cell transplant patients

Abstract 3439: Interaction between cutaneous human papillomavirus infection and telomere length in association with cutaneous squamous cell carcinoma

Prospective study of seroreactivity to JC virus T-antigen and risk of colorectal cancers and adenomas

Socioeconomic factors and the risk for sarcoma

Aspirin and Acetaminophen Use and the Risk of Cervical Cancer

Merkel cell polyomavirus (MCV) T-antigen seroreactivity, MCV DNA in eyebrow hairs, and squamous cell carcinoma

Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide

Genetic polymorphisms of ATP-binding cassette (ABC) proteins, overall survival and drug toxicity in patients with Acute Myeloid Leukemia

Abstract 4960: Recent ultraviolet radiation exposure and circulating immunosuppressive T-regulatory cells

Skin homing and highly suppressive (CD45RA−CD27−) Tregs associated with ultraviolet radiation exposure

Subsequent Primary Malignancies Among Myelodysplastic Syndrome Patients Treated with or without Lenalidomide

Subsequent Primary Malignancies Among Multiple Myeloma Patients Treated with or without Lenalidomide

Lenalidomide and Risk of Acute Myeloid Leukemia (AML) Transformation Among Myelodysplastic Syndrome (MDS) Patients

Abstract B58: Sunlight exposure and overall survival in melanoma, colon cancer, and non-Hodgkin's lymphoma

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

Natural History of Cutaneous Human Papillomavirus (HPV) Infection in Men: The HIM Study: e104843

Isolation and characterization of a novel putative human polyomavirus

The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing Intravesical System (TAR-200) in American Urological Association–defined Intermediate-risk Non–muscle-invasive Bladder Cancer Patients: A Phase 1b Study

SunRISe-1: Phase 2b study of TAR-200 plus cetrelimab, TAR-200 alone, or cetrelimab alone in participants with high-risk nonmuscle-invasive bladder cancer unresponsive to Bacillus Calmette-Guérin who are ineligible for or decline radical cystectomy

Suchergebnisse filtern